Top 10 search results for "new zealand positive for medication been changes" in Treatments. To see all results and access other features, sign up for free.

Zurzuvae (Zuranolone)

Overview
Zurzuvae is approved by the U.S. Food and Drug Administration (FDA) to treat postpartum depression in adults. It’s prescribed for people experiencing depression after childbirth. Zurzuvae can be taken by itself…

Zulresso (Brexanolone)

The Zulresso brand name has been discontinued in the U.S.

Overview
Zulresso is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postpartum depression (PPD) in people 15 and older. As of July…

Trintellix (Vortioxetine)

Overview
Trintellix is a prescription drug approved by the Food and Drug Administration (FDA) to treat major depressive disorder. Trintellix is also referred to by its drug name, Vortioxetine. Trintellix was previously… read more

Provigil (Modafinil)

Overview
Provigil is a prescription medication approved by the Food and Drug Administration (FDA) for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder.… read more

Spravato (Esketamine)

Overview
Spravato is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with treatment-resistant depression (TRD), either alone or in combination with an oral…

Cobenfy (Xanomeline and Trospium Chloride)

Overview
Cobenfy is a combination medication of xanomeline, a muscarinic agonist, and trospium chloride, a muscarinic antagonist, approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia…

Erzofri ((Paliperidone Palmitate))

Overview
Erzofri, approved by the U.S. Food and Drug Administration (FDA), is an atypical (second-generation) antipsychotic drug used for treating schizophrenia in adults. People who are new to Erzofri or similar drugs…

Abilify (Aripiprazole)

Overview
Abilify is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, the acute treatment of manic and mixed episodes associated with bipolar 1 disorder, and as an adjunctive…

Abilify Maintena (Aripiprazole)

Overview
Abilify Maintena is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and the maintenance monotherapy (single-drug treatment) of bipolar 1 disorder in adults. This…

Abilify Asimtufii (Aripiprazole)

Overview
Abilify Asimtufii is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and as a maintenance monotherapy (single-drug treatment) for bipolar 1 disorder in adults…